{
    "Orphapacket": {
        "ORPHApacketId": "2102",
        "creationDate": "2024-12-03 10:13:55",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2024",
        "ORPHAcode": "2102",
        "Label": "GTP cyclohydrolase I deficiency",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_2102",
        "DisorderType": {
            "value": "Clinical subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377796"
        },
        "Synonyms": [
            {
                "Synonym": "GTPCH deficiency"
            },
            {
                "Synonym": "Hyperphenylalaninemia due to GTP cyclohydrolase deficiency"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "233910",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "GTP-cyclohydrolase I deficiency an autosomal recessive genetic disorder is one of the causes of malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency. Not only does tetrahydrobiopterin deficiency cause hyperphenylalaninemia it is also responsible for defective neurotransmission of monoamines because of malfunctioning tyrosine and tryptophan hydroxylases both tetrahydrobiopterin-dependent hydroxylases."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "GCH1",
                    "Name": "GTP cyclohydrolase 1",
                    "ExternalReferences": [],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "238583",
                        "Label": "Hyperphenylalaninemia due to tetrahydrobiopterin deficiency"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case(s)",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Infancy"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Neonatal"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}